Literature DB >> 1915849

Identification of the site phosphorylated by casein kinase II in smooth muscle caldesmon.

A Wawrzynow1, J H Collins, N V Bogatcheva, A V Vorotnikov, N B Gusev.   

Abstract

Phosphorylation of avian gizzard caldesmon by casein kinase II was investigated. The enzyme incorporates about 1 mol of phosphate per mol of caldesmon. All sites of phosphorylation are located in short chymotryptic peptides with Mr 25-27 kDa or in the short N-terminal peptide formed after cleavage of chicken gizzard caldesmon at Cys153. The primary structure of the tryptic peptide containing the main site of duck gizzard caldesmon phosphorylation is S-E-V-N-A-Q-N-X-V-A-E-D-E-T-K, where X is an unidentified residue, presumed to be phosphoserine. Thus, Ser73 is the main site phosphorylated by casein kinase II in avian gizzard caldesmon.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1915849     DOI: 10.1016/0014-5793(91)81072-g

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  8 in total

1.  Utilization of troponin C as a model calcium-binding protein for mapping of the calmodulin-binding sites of caldesmon.

Authors:  A A Polyakov; N B Gusev
Journal:  Biochem J       Date:  1997-02-01       Impact factor: 3.857

2.  Activation of MAP kinases and phosphorylation of caldesmon in canine colonic smooth muscle.

Authors:  W T Gerthoffer; I A Yamboliev; M Shearer; J Pohl; R Haynes; S Dang; K Sato; J R Sellers
Journal:  J Physiol       Date:  1996-09-15       Impact factor: 5.182

3.  Phosphorylation by casein kinase II affects the interaction of caldesmon with smooth muscle myosin and tropomyosin.

Authors:  N V Bogatcheva; A V Vorotnikov; K G Birukov; V P Shirinsky; N B Gusev
Journal:  Biochem J       Date:  1993-03-01       Impact factor: 3.857

4.  Phosphorylation of caldesmon by smooth-muscle casein kinase II.

Authors:  C Sutherland; B S Renaux; D J McKay; M P Walsh
Journal:  J Muscle Res Cell Motil       Date:  1994-08       Impact factor: 2.698

Review 5.  Caldesmon as a therapeutic target for proliferative vascular diseases.

Authors:  Chi-Ming Hai
Journal:  Mini Rev Med Chem       Date:  2008-10       Impact factor: 3.862

6.  Reversal of caldesmon binding to myosin with calcium-calmodulin or by phosphorylating caldesmon.

Authors:  M E Hemric; F W Lu; R Shrager; J Carey; J M Chalovich
Journal:  J Biol Chem       Date:  1993-07-15       Impact factor: 5.157

7.  Smooth-muscle caldesmon phosphatase is SMP-I, a type 2A protein phosphatase.

Authors:  M D Pato; C Sutherland; S J Winder; M P Walsh
Journal:  Biochem J       Date:  1993-07-01       Impact factor: 3.857

Review 8.  Calmodulin and the regulation of smooth muscle contraction.

Authors:  M P Walsh
Journal:  Mol Cell Biochem       Date:  1994-06-15       Impact factor: 3.396

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.